01 March 2006
Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
Marjana GlaserMed Sci Monit 2006; 12(3): CR113-117 :: ID: 447108
Abstract
Background: In patients with terminal renal failure, the most frequentlynoted hematological change is normocytic normochromic anemia. As not all anemic patients respond in thesame way to treatment with human erythropoietin, the aim of our investigation was to confirm the hypothesisthat the origin of this anemia is multifactorial. Material/Methods: Therefore we cultivated peripheralblood CFU GEMM, CFU GM, and BFU E in 65 patients treated by hemodialysis, subdivided in two groups accordingto creatinine concentration (Group 1: 900 micromol/l). Hematopoietic stemcells were cultivated on methylcellulose with growth factors added. Results: Growth inhibition of BFUE and CFU GM and a negative correlation between CFU GEMM, CFU GM, and BFU E growth and urea concentrationwere found in the entire group of patients. CFU GEMM growth in Group 2 was inhibited. Positive correlationbetween CFU GM and BFU E, CFU GEMM and BFU E, and CFU GM and CFU GEMM growth was established. In Group1 a negative correlation between BFU E and CFU GM growth and creatinine concentration was found, andin Group 2 a negative correlation between BFU E and CFU GM growth and urea concentration. Conclusions:Relatively decreased erythropoietin concentration is one of the major causes of renal anemia. As CFUGM and CFU GEMM growth was decreased, hematopoiesis must be disturbed at a higher level and is affectedby other factors connected with uremia, such as the lack of T[sub]4[/sub] lymphocytes and the dialysis procedure.
Keywords: Colony-Forming Units Assay, Enzyme-Linked Immunosorbent Assay, Erythroid Precursor Cells - drug effects, Erythropoietin - pharmacology, Hematopoiesis - drug effects, Hematopoietic Cell Growth Factors - pharmacology, Hematopoietic Stem Cells - drug effects, Kidney Failure, Chronic - pathology, Renal Dialysis
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952